Current views of haemolytic streptococcal pathogenesis
Tan, Lionel K K, Eccersley, Lydia R J, Sriskandan, Shiranee
Published in Current opinion in infectious diseases (01.04.2014)
Published in Current opinion in infectious diseases (01.04.2014)
Get more information
Journal Article
International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma
Khwaja, Jahanzaib, Kirkwood, Amy A, Isbell, Lisa K, Steffanoni, Sara, Goradia, Harshita, Pospiech, Lisa, Fail, Thomas, Nicholson, Emma, Fletcher, Kate, Linton, Kim M, Parsons, Katrina E, Elmusharaf, Nagah, Eccersley, Lydia, Eyre, Toby A, Chaganti, Sridhar, Smith, Jeffrey, Thakrar, Nisha, Kutilina, Alexandra, Calimeri, Teresa, Martinez-Calle, Nicolas, El-Sharkawi, Dima, Osborne, Wendy, Illerhaus, Gerald, Fox, Christopher P, Ferreri, Andrés J M, Schorb, Elisabeth, Cwynarski, Kate
Published in Haematologica (Roma) (01.03.2023)
Published in Haematologica (Roma) (01.03.2023)
Get full text
Journal Article
Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia
Porkka, Kimmo, Koskenvesa, Perttu, Lundán, Tuija, Rimpiläinen, Johanna, Mustjoki, Satu, Smykla, Richard, Wild, Robert, Luo, Roger, Arnan, Montserrat, Brethon, Benoit, Eccersley, Lydia, Hjorth-Hansen, Henrik, Höglund, Martin, Klamova, Hana, Knutsen, Håvar, Parikh, Suhag, Raffoux, Emmanuel, Gruber, Franz, Brito-Babapulle, Finella, Dombret, Hervé, Duarte, Rafael F., Elonen, Erkki, Paquette, Ron, Zwaan, C.Michel, Lee, Francis Y.F.
Published in Blood (15.08.2008)
Published in Blood (15.08.2008)
Get full text
Journal Article
Paraneoplastic pemphigus associated with systemic mastocytosis
Eccersley, Lydia R.J., Hoffbrand, A. Victor, Rustin, Malcolm H.A., McNamara, Christopher J.
Published in American journal of hematology (01.12.2009)
Published in American journal of hematology (01.12.2009)
Get full text
Journal Article
Cessation of Ciprofloxacin Prophylaxis in Hemato-Oncology Patients
Caldwell, Louise, Bapat, Anjaneya, Drumright, Lydia N, Lambourne, Jonathan, Jimenez-England, Fergus G, Aries, James, Eccersley, Lydia, Hallam, Simon, Montoto, Silvia, Oakervee, Heather, Riches, John, Agrawal, Samir G
Published in Clinical infectious diseases (24.08.2022)
Published in Clinical infectious diseases (24.08.2022)
Get full text
Journal Article
Results from the randomized phase III DREAMM-7 study of belantamab mafodotin (belamaf) + bortezomib, and dexamethasone (BVd) vs daratumumab, bortezomib, and dexamethasone (DVd) in relapsed/refractory multiple myeloma (RRMM)
Mateos, Maria-Victoria, Robak, Pawel, Hus, Marek, Xia, Zhongjun, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios A., Cerchione, Claudio, Riccio, Antonio, McKeown, Astrid, Rogers, Rachel, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania
Published in Journal of clinical oncology (06.02.2024)
Published in Journal of clinical oncology (06.02.2024)
Get full text
Journal Article
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
Hungria, Vania, Robak, Pawel, Hus, Marek, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, Ribas de Almeida, Ana Carolina, Hajek, Roman, Kim, Kihyun, Grosicki, Sebastian, Sia, Hanlon, Bryant, Adam, Pitombeira de Lacerda, Marcelo, Aparecida Martinez, Gracia, Sureda Balarí, Anna Maria, Sandhu, Irwindeep, Cerchione, Claudio, Ganly, Peter, Dimopoulos, Meletios, Fu, Chengcheng, Garg, Mamta, Abdallah, Al-Ola, Oriol, Albert, Gatt, Moshe E., Cavo, Michele, Rifkin, Robert, Fujisaki, Tomoaki, Mielnik, Michał, Pirooz, Nick, McKeown, Astrid, McNamara, Simon, Zhou, Xiangdong, Nichols, Maureen, Lewis, Eric, Rogers, Rachel, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Mateos, María-Victoria
Published in The New England journal of medicine (01.08.2024)
Published in The New England journal of medicine (01.08.2024)
Get full text
Journal Article
Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience
Jurgensen‐Rauch, Amanda, Gibbs, Suzanne, Farrell, Maresa, Aries, James, Grantham, Marianne, Eccersley, Lydia, Gribben, John, Hallam, Simon, Oakervee, Heather, Cavenagh, Jamie, Davies, Jeff, Sive, Jonathan
Published in British journal of haematology (01.04.2021)
Published in British journal of haematology (01.04.2021)
Get full text
Journal Article
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study
Camilleri, Marquita, Cuadrado, Maria, Phillips, Elizabeth, Wilson, William, Jenner, Richard, Pang, Gavin, Kamora, Sumaiya, Streetly, Matthew, Popat, Rakesh, Bygrave, Ceri, Owen, Roger, Cavenagh, James, Chapman, Mike, Sive, Jonathan, Eccersley, Lydia, Sheaff, Michael, Benjamin, Reuben, Ramasamy, Karthik, Cook, Gordon, Virchis, Andres, Chavda, Selina J., Clifton‐Hadley, Laura, Scully, Marie Anne, Yong, Kwee
Published in British journal of haematology (01.05.2021)
Published in British journal of haematology (01.05.2021)
Get full text
Journal Article
PET-CT for Assessment of Multiple Myeloma Disease Burden and Metabolic Response before and after Carfilzomib-Based Induction, Consolidation and Carfilzomib Maintenance Therapy: Data from the UK NCRI Cardamon Study
Bygrave, Ceri A, Subesinghe, Manil, Wilson, William, Popat, Rakesh, Ramasamy, Karthik, Pang, Gavin, Jenner, Richard, Kamora, Sumaiya, Dadaga, Tushhar, Pike, Lucy, Streetly, Matthew, Camilleri, Marquita, Owen, Roger G, Cavenagh, James, Sive, Jonathan, Chapman, Michael, Phillips, Elizabeth H, Chavda, Selina J, Cuadrado, Maria del Mar, Benjamin, Reuben, Eccersley, Lydia, Moore, Sally, Banerjee, Lalita, Clifton-Hadley, Laura, Barrington, Sally F, Yong, Kwee
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
MM-557 DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) in Relapsed/Refractory Multiple Myeloma (RRMM)
Victoria, Maria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, de Almeida, Ana Carolina, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
DREAMM-7 Update: Subgroup Analyses From a Phase 3 Trial of Belantamab Mafodotin (Belamaf) + Bortezomib and Dexamethasone (BVd) vs Daratumumab, Bortezomib, and Dexamethasone (DVd) in Relapsed/Refractory Multiple Myeloma (RRMM)
Mateos, Maria Victoria, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Joy Ho, P., Carolina de Almeida, Ana, Hajek, Roman, Kim, Kihyun, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Kazeem, Benga, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Hungria, Vania
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
P-396 Characterization and Management of Ocular Events in Patients (Pts) Treated With Belantamab Mafodotin (Belamaf) Plus Bortezomib and Dexamethasone (BVd) in the DREAMM-7 Study
Hungria, Vania T.M., Robak, Pawel, Hus, Marek, Fu, Chengcheng, Zherebtsova, Vera, Ward, Christopher, Ho, P. Joy, Hájek, Roman, Kim, Kihyun, de Lacerda, Marcelo Pitombeira, Aparecida-Martinez, Gracia, Dimopoulos, Meletios, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Rogers, Rachel, Kazeem, Benga, Wang, Zhaohui, Baig, Hena, Eccersley, Lydia, Roy-Ghanta, Sumita, Opalinska, Joanna, Manteca, María-Victoria Mateos
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
Patient-Reported Outcomes From the DREAMM-7 Randomized Phase 3 Study Comparing Belantamab Mafodotin (Belamaf), Bortezomib, and Dexamethasone vs Daratumumab, Bortezomib, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Hungria, Vania, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, Carolina de Almeida, Ana, Joy Ho, P., Hajek, Roman, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Baig, Hena, Eccersley, Lydia, Pompilus, Farrah, McNamara, Simon, Paul Lin, Chee, Roy-Ghanta, Sumita, Opalinska, Joanna, Victoria Mateos, Maria
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article
MM-542 Patient-Reported Outcomes From the DREAMM-7 Randomized Phase 3 Study Comparing Belantamab Mafodotin (Belamaf), Bortezomib, and Dexamethasone vs Daratumumab Bortezomib, and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
Hungria, Vania, Robak, Pawel, Hus, Marek, Fu, ChengCheng, Zherebtsova, Vera, Ward, Christopher, de Almeida, Ana Carolina, Ho, P. Joy, Hajek, Roman, Cerchione, Claudio, Pirooz, Nick, McKeown, Astrid, Baig, Hena, Eccersley, Lydia, Pompilus, Farrah, McNamara, Simon, Paul Lin, Chee, Roy-Ghanta, Sumita, Opalinska, Joanna, Victoria, Maria
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2024)
Get full text
Journal Article